In particular, ARHGAP5‐AS1 could interrupt interactions between CSDE1 and TRIM28, stabilise oncoprotein CSDE1, boost translation of VIM and RAC1 mRNAs, stimulate the ERK signalling and, thus, accelerate HCC progression. This evidence concerns the gene ARHGAP5 and hepatocellular carcinoma.